Cargando…
Disclosing transcriptomics network-based signatures of glioma heterogeneity using sparse methods
Gliomas are primary malignant brain tumors with poor survival and high resistance to available treatments. Improving the molecular understanding of glioma and disclosing novel biomarkers of tumor development and progression could help to find novel targeted therapies for this type of cancer. Public...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523751/ https://www.ncbi.nlm.nih.gov/pubmed/37752578 http://dx.doi.org/10.1186/s13040-023-00341-1 |